Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature Publisher Pubmed



Tootee A1 ; Nikbin B2 ; Ghahary A6 ; Esfahani EN1 ; Arjmand B3 ; Aghayan H3 ; Qorbani M4 ; Larijani B5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center of Molecular Immunology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Cell therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Non-communicable Diseases Research Cen-ter, Alborz University of Medical Sciences, Karaj, Iran
  5. 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. British Columbia Professional Firefighters' Burn and Wound Healing Research Laboratory, Department of Surgery, Plastic Surgery, University of British Columbia, Vancouver, Canada

Source: Endocrine# Metabolic and Immune Disorders - Drug Targets Published:2022


Abstract

Type 1 Diabetes (T1D) is a complex autoimmune disorder which occurs as a result of an intricate series of pathologic interactions between pancreatic β-cells and a wide range of components of both the innate and the adaptive immune systems. Stem-cell therapy, a recently-emerged potentially therapeutic option for curative treatment of diabetes, is demonstrated to cause significant alternations to both different immune cells such as macrophages, natural killer (NK) cells, dendritic cells, T cells, and B cells and non-cellular elements, including serum cytokines and different components of the complement system. Although there exists overwhelming evidence indicating that the documented therapeutic effects of stem cells on patients with T1D are primarily due to their potential for immune regulation rather than pancreatic tissue regeneration, to date, the precise underlying mechanisms remain obscure. On the other hand, immune-mediated rejection of stem cells remains one of the main obstacles to regenerative medicine. Moreover, the consequences of ef-ferocytosis of stem-cells by the recipients’ lung-resident macrophages have recently emerged as a mechanism responsible for some immune-mediated therapeutic effects of stem-cells. This review focuses on the nature of the interactions amongst different compartments of the immune systems which are involved in the pathogenesis of T1D and provides an explanation as to how stem cel-l-based interventions can influence immune system and maintain the physiologic equilibrium. © 2022, Bentham Science Publishers. All rights reserved.
Related Docs
View other Related Docs
1. Mesenchymal Stem Cells: Rising Concerns Over Their Application in Treatment of Type One Diabetes Mellitus, Journal of Diabetes Research (2015)
2. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
3. Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus, Iranian Journal of Public Health (2015)
4. Mesenchymal Stem Cells and Natural Killer Cells Interaction Mechanisms and Potential Clinical Applications, Stem Cell Research and Therapy (2022)
5. Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations, Medical Journal of the Islamic Republic of Iran (2022)
6. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside, Iranian Journal of Kidney Diseases (2019)
7. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
8. Assessment of Immune-Alternations and Their Correlations With Therapeutic Outcomes of Transplantation of Autologous Mesenchymal and Allogenic Fetal Stem Cells in Patients With Type 1 Diabetes: A Study Protocol, Journal of Diabetes and Metabolic Disorders (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (7)
Bagher Larijani (7)
Other Related Docs
9. Genetically Engineered Mesenchymal Stromal Cells As a New Trend for Treatment of Severe Acute Graft-Versus-Host Disease, Clinical and Experimental Immunology (2022)
10. Transplant and Kidney Repair, Stem Cells in Urology (2020)
11. Therapy of Endocrine Disease: Islet Transplantation for Type 1 Diabetes: So Close and yet so Far Away, European Journal of Endocrinology (2015)
12. Manipulated Mesenchymal Stem Cells Applications in Neurodegenerative Diseases, International Journal of Stem Cells (2020)
13. Mesenchymal Stem Cells Induce Expansion of Regulatory T Cells in Abortion-Prone Mice, Reproduction (2021)
14. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
15. The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy Via the Modulation of Inflammatory Milieu, Journal of Clinical Medicine (2019)
16. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
17. Immunomodulatory and Protective Effects of Adipose Tissue-Derived Mesenchymal Stem Cells in an Allograft Islet Composite Transplantation for Experimental Autoimmune Type 1 Diabetes, Immunology Letters (2017)
18. Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I/Ii Randomized Placebo-Controlled Clinical Trial, Stem Cell Research and Therapy (2022)
19. Endometrial and Menstrual Blood Mesenchymal Stem/Stromal Cells: Biological Properties and Clinical Application, Frontiers in Cell and Developmental Biology (2020)
20. Investigating the Route of Administration and Efficacy of Adipose Tissue-Derived Mesenchymal Stem Cells and Conditioned Medium in Type 1 Diabetic Mice, Inflammopharmacology (2020)
21. Adipose Tissue-Derived Mesenchymal Stem Cells Exert in Vitro Immunomodulatory and Beta Cell Protective Functions in Streptozotocin-Induced Diabetic Mice Model, Journal of Diabetes Research (2015)
22. Natural Killer Cells From the Subcutaneous Adipose Tissue Underexpress the Nkp30 and Nkp44 in Obese Persons and Are Less Active Against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells, Frontiers in Immunology (2017)
23. Human Menstrual Blood-Derived Stromal/Stem Cells Modulate Functional Features of Natural Killer Cells, Scientific Reports (2019)
24. Multipotent Stem Cell and Current Application, Acta Medica Iranica (2017)
25. Bone Marrow Mesenchymal Stromal Cells for Diabetes Therapy: Touch, Fuse, and Fix?, Stem Cell Research and Therapy (2022)
26. Evaluation of Immunomodulatory Effects of Co-Culture or Supernatant of Dexamethasone or Ifn-Γ-Treated Adipose-Derived Mesenchymal Stem Cells on Spleen Mononuclear Cells, European Cytokine Network (2022)
27. Therapeutic and Immunomodulatory Potentials of Mesenchymal Stromal/Stem Cells and Immune Checkpoints Related Molecules, Biomarker Research (2024)
28. Effect of Efferocytosis of Apoptotic Mesenchymal Stem Cells (Mscs) on C57bl/6 Peritoneal Macrophages Function, Life Sciences (2018)
29. Generation of High Yield Insulin-Producing Cells (Ipcs) From Various Sources of Stem Cells, Vitamins and Hormones (2021)
30. The Role of Inflammatory Cytokines and Tumor Associated Macrophages (Tams) in Microenvironment of Pancreatic Cancer, Cytokine and Growth Factor Reviews (2018)
31. Cell Therapy in Transplantation: A Comprehensive Review of the Current Applications of Cell Therapy in Transplant Patients With the Focus on Tregs, Car Tregs, and Mesenchymal Stem Cells, International Immunopharmacology (2021)
32. The Sdldl Reduces Mrc1 Expression Level and Secretion of Histamin E in Differentiated M2-Macrophages From Patients With Coronary Artery Stenosis, Cardiovascular and Hematological Disorders - Drug Targets (2017)
33. Immunomodulatory Activity of Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells Prolongs Allogenic Skin Graft Survival in Nonhuman Primates, Cell Journal (2021)
34. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
35. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
36. Targeting Macrophage-Mediated Tumor Cell Phagocytosis: An Overview of Phagocytosis Checkpoints Blockade, Nanomedicine Intervention, and Engineered Car-Macrophage Therapy, International Immunopharmacology (2022)
37. The Role of Memory T Cells in Type 1 Diabetes: Phenotypes, Mechanisms, and Therapeutic Implications, Autoimmunity Reviews (2025)
38. The Most Ideal Pancreas Extracellular Matrix As a Platform for Pancreas Bioengineering: Decellularization/Recellularization Protocols, Advances in Experimental Medicine and Biology (2021)
39. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
40. Mesenchymal Stem Cell Transplantation in Systemic Lupus Erythematous, a Mesenchymal Stem Cell Disorder, Lupus (2018)
41. A Dermal Equivalent Engineered With Tgf-Β3 Expressing Bone Marrow Stromal Cells and Amniotic Membrane: Cosmetic Healing of Full-Thickness Skin Wounds in Rats, Artificial Organs (2016)
42. The Mechanisms of Cellular Crosstalk Between Mesenchymal Stem Cells and Natural Killer Cells: Therapeutic Implications, Journal of Cellular Physiology (2021)
43. Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders, Stem Cell Research and Therapy (2021)
44. Alopecia Areata: A Review of Disease Pathogenesis, British Journal of Dermatology (2018)
45. Germline Cells Derived From Mesenchymal Stem Cells, With the Focus on Wharton's Jelly, Asian Pacific Journal of Reproduction (2018)
46. Extracellular Vesicles Isolated From Mesenchymal Stem Cell (Mscs) Negatively Regulates Human T Cell Survival by Inducing Caspase Cascade and Inhibiting Anti-Apoptotic Proteins, Nanomedicine Research Journal (2022)
47. Human Studies of the Efficacy and Safety of Stem Cells in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis, Stem Cell Research and Therapy (2024)
48. Mesenchymal Stromal Cells in Bone Marrow Niche of Patients With Multiple Myeloma: A Double-Edged Sword, Cancer Cell International (2025)
49. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
50. Umbilical Cord Mesenchymal Stem Cells As Well As Their Released Exosomes Suppress Proliferation of Activated Pbmcs in Multiple Sclerosis, Scandinavian Journal of Immunology (2021)